Global Intravenous Immunoglobulin (IVIg) Market Insights and Forecast to 2028

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Intravenous Immunoglobulin (IVIg) Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 IVIg Liquid
  • 1.2.3 IVIg Powder
• 1.3 Market by Application
  • 1.3.1 Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Immunodeficiency
  • 1.3.3 Autoimmune Disease
  • 1.3.4 Acute Infection
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Intravenous Immunoglobulin (IVIg) Sales Estimates and Forecasts 2017-2028
• 2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Estimates and Forecasts 2017-2028
• 2.3 Global Intravenous Immunoglobulin (IVIg) Revenue by Region: 2017 VS 2021 VS 2028
• 2.4 Global Intravenous Immunoglobulin (IVIg) Sales by Region
  • 2.4.1 Global Intravenous Immunoglobulin (IVIg) Sales by Region (2017-2022)
  • 2.4.2 Global Sales Intravenous Immunoglobulin (IVIg) by Region (2023-2028)
• 2.5 Global Intravenous Immunoglobulin (IVIg) Revenue by Region
  • 2.5.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Region (2017-2022)
  • 2.5.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Region (2023-2028)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Intravenous Immunoglobulin (IVIg) Sales by Manufacturers
  • 3.1.1 Global Top Intravenous Immunoglobulin (IVIg) Manufacturers by Sales (2017-2022)
  • 3.1.2 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturers (2017-2022)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Intravenous Immunoglobulin (IVIg) in 2021
• 3.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers
  • 3.2.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2017-2022)
  • 3.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturers (2017-2022)
  • 3.2.3 Global Top 10 and Top 5 Companies by Intravenous Immunoglobulin (IVIg) Revenue in 2021
• 3.3 Global Intravenous Immunoglobulin (IVIg) Sales Price by Manufacturers (2017-2022)
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Intravenous Immunoglobulin (IVIg) Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type
  • 4.1.1 Global Intravenous Immunoglobulin (IVIg) Historical Sales by Type (2017-2022)
  • 4.1.2 Global Intravenous Immunoglobulin (IVIg) Forecasted Sales by Type (2023-2028)
  • 4.1.3 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2017-2028)
• 4.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Type
  • 4.2.1 Global Intravenous Immunoglobulin (IVIg) Historical Revenue by Type (2017-2022)
  • 4.2.2 Global Intravenous Immunoglobulin (IVIg) Forecasted Revenue by Type (2023-2028)
  • 4.2.3 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2017-2028)
• 4.3 Global Intravenous Immunoglobulin (IVIg) Price by Type
  • 4.3.1 Global Intravenous Immunoglobulin (IVIg) Price by Type (2017-2022)
  • 4.3.2 Global Intravenous Immunoglobulin (IVIg) Price Forecast by Type (2023-2028)

5 Market Size by Application

• 5.1 Global Intravenous Immunoglobulin (IVIg) Sales by Application
  • 5.1.1 Global Intravenous Immunoglobulin (IVIg) Historical Sales by Application (2017-2022)
  • 5.1.2 Global Intravenous Immunoglobulin (IVIg) Forecasted Sales by Application (2023-2028)
  • 5.1.3 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2017-2028)
• 5.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Application
  • 5.2.1 Global Intravenous Immunoglobulin (IVIg) Historical Revenue by Application (2017-2022)
  • 5.2.2 Global Intravenous Immunoglobulin (IVIg) Forecasted Revenue by Application (2023-2028)
  • 5.2.3 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2017-2028)
• 5.3 Global Intravenous Immunoglobulin (IVIg) Price by Application
  • 5.3.1 Global Intravenous Immunoglobulin (IVIg) Price by Application (2017-2022)
  • 5.3.2 Global Intravenous Immunoglobulin (IVIg) Price Forecast by Application (2023-2028)

6 North America

• 6.1 North America Intravenous Immunoglobulin (IVIg) Market Size by Type
  • 6.1.1 North America Intravenous Immunoglobulin (IVIg) Sales by Type (2017-2028)
  • 6.1.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Type (2017-2028)
• 6.2 North America Intravenous Immunoglobulin (IVIg) Market Size by Application
  • 6.2.1 North America Intravenous Immunoglobulin (IVIg) Sales by Application (2017-2028)
  • 6.2.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Application (2017-2028)
• 6.3 North America Intravenous Immunoglobulin (IVIg) Market Size by Country
  • 6.3.1 North America Intravenous Immunoglobulin (IVIg) Sales by Country (2017-2028)
  • 6.3.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2017-2028)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Intravenous Immunoglobulin (IVIg) Market Size by Type
  • 7.1.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2017-2028)
  • 7.1.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Type (2017-2028)
• 7.2 Europe Intravenous Immunoglobulin (IVIg) Market Size by Application
  • 7.2.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2017-2028)
  • 7.2.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Application (2017-2028)
• 7.3 Europe Intravenous Immunoglobulin (IVIg) Market Size by Country
  • 7.3.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2017-2028)
  • 7.3.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2017-2028)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Size by Type
  • 8.1.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Type (2017-2028)
  • 8.1.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Type (2017-2028)
• 8.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Size by Application
  • 8.2.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Application (2017-2028)
  • 8.2.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Application (2017-2028)
• 8.3 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Size by Region
  • 8.3.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (2017-2028)
  • 8.3.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region (2017-2028)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 China Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia

9 Latin America

• 9.1 Latin America Intravenous Immunoglobulin (IVIg) Market Size by Type
  • 9.1.1 Latin America Intravenous Immunoglobulin (IVIg) Sales by Type (2017-2028)
  • 9.1.2 Latin America Intravenous Immunoglobulin (IVIg) Revenue by Type (2017-2028)
• 9.2 Latin America Intravenous Immunoglobulin (IVIg) Market Size by Application
  • 9.2.1 Latin America Intravenous Immunoglobulin (IVIg) Sales by Application (2017-2028)
  • 9.2.2 Latin America Intravenous Immunoglobulin (IVIg) Revenue by Application (2017-2028)
• 9.3 Latin America Intravenous Immunoglobulin (IVIg) Market Size by Country
  • 9.3.1 Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2017-2028)
  • 9.3.2 Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (2017-2028)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

10 Middle East and Africa

• 10.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Type
  • 10.1.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Type (2017-2028)
  • 10.1.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Type (2017-2028)
• 10.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Application
  • 10.2.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Application (2017-2028)
  • 10.2.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Application (2017-2028)
• 10.3 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Country
  • 10.3.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2017-2028)
  • 10.3.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2017-2028)
  • 10.3.3 Turkey
  • 10.3.4 Saudi Arabia

11 Company Profiles

• 11.1 Baxter
  • 11.1.1 Baxter Corporation Information
  • 11.1.2 Baxter Overview
  • 11.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.1.4 Baxter Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Baxter Recent Developments
• 11.2 Grifols
  • 11.2.1 Grifols Corporation Information
  • 11.2.2 Grifols Overview
  • 11.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.2.4 Grifols Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Grifols Recent Developments
• 11.3 CSL
  • 11.3.1 CSL Corporation Information
  • 11.3.2 CSL Overview
  • 11.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.3.4 CSL Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 CSL Recent Developments
• 11.4 Octapharma
  • 11.4.1 Octapharma Corporation Information
  • 11.4.2 Octapharma Overview
  • 11.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Octapharma Recent Developments
• 11.5 Biotest
  • 11.5.1 Biotest Corporation Information
  • 11.5.2 Biotest Overview
  • 11.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.5.4 Biotest Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Biotest Recent Developments
• 11.6 Kedrion
  • 11.6.1 Kedrion Corporation Information
  • 11.6.2 Kedrion Overview
  • 11.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Kedrion Recent Developments
• 11.7 Hualan Bio
  • 11.7.1 Hualan Bio Corporation Information
  • 11.7.2 Hualan Bio Overview
  • 11.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Hualan Bio Recent Developments
• 11.8 CNBG
  • 11.8.1 CNBG Corporation Information
  • 11.8.2 CNBG Overview
  • 11.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.8.4 CNBG Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 CNBG Recent Developments
• 11.9 Shanghai RAAS
  • 11.9.1 Shanghai RAAS Corporation Information
  • 11.9.2 Shanghai RAAS Overview
  • 11.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Shanghai RAAS Recent Developments
• 11.10 CBPO
  • 11.10.1 CBPO Corporation Information
  • 11.10.2 CBPO Overview
  • 11.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.10.4 CBPO Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 CBPO Recent Developments
• 11.11 LFB Group
  • 11.11.1 LFB Group Corporation Information
  • 11.11.2 LFB Group Overview
  • 11.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.11.4 LFB Group Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 LFB Group Recent Developments
• 11.12 BPL
  • 11.12.1 BPL Corporation Information
  • 11.12.2 BPL Overview
  • 11.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.12.4 BPL Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 BPL Recent Developments
• 11.13 Sichuan Yuanda Shuyang
  • 11.13.1 Sichuan Yuanda Shuyang Corporation Information
  • 11.13.2 Sichuan Yuanda Shuyang Overview
  • 11.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.13.4 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.13.5 Sichuan Yuanda Shuyang Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Intravenous Immunoglobulin (IVIg) Industry Chain Analysis
• 12.2 Intravenous Immunoglobulin (IVIg) Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Intravenous Immunoglobulin (IVIg) Production Mode & Process
• 12.4 Intravenous Immunoglobulin (IVIg) Sales and Marketing
  • 12.4.1 Intravenous Immunoglobulin (IVIg) Sales Channels
  • 12.4.2 Intravenous Immunoglobulin (IVIg) Distributors
• 12.5 Intravenous Immunoglobulin (IVIg) Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Intravenous Immunoglobulin (IVIg) Industry Trends
• 13.2 Intravenous Immunoglobulin (IVIg) Market Drivers
• 13.3 Intravenous Immunoglobulin (IVIg) Market Challenges
• 13.4 Intravenous Immunoglobulin (IVIg) Market Restraints

14 Key Findings in The Global Intravenous Immunoglobulin (IVIg) Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

• Table 1. Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
• Table 2. Major Manufacturers of IVIg Liquid
• Table 3. Major Manufacturers of IVIg Powder
• Table 4. Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
• Table 5. Global Intravenous Immunoglobulin (IVIg) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
• Table 6. Global Intravenous Immunoglobulin (IVIg) Sales by Region (2017-2022) & (K Bottle)
• Table 7. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2017-2022)
• Table 8. Global Intravenous Immunoglobulin (IVIg) Sales by Region (2023-2028) & (K Bottle)
• Table 9. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2023-2028)
• Table 10. Global Intravenous Immunoglobulin (IVIg) Revenue by Region (2017-2022) & (US$ Million)
• Table 11. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2017-2022)
• Table 12. Global Intravenous Immunoglobulin (IVIg) Revenue by Region (2023-2028) & (US$ Million)
• Table 13. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2023-2028)
• Table 14. Global Intravenous Immunoglobulin (IVIg) Sales by Manufacturers (2017-2022) & (K Bottle)
• Table 15. Global Intravenous Immunoglobulin (IVIg) Sales Share by Manufacturers (2017-2022)
• Table 16. Global Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2017-2022) & (US$ Million)
• Table 17. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturers (2017-2022)
• Table 18. Intravenous Immunoglobulin (IVIg) Price by Manufacturers (2017-2022) &(USD/Bottle)
• Table 19. Global Intravenous Immunoglobulin (IVIg) Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 20. Global Intravenous Immunoglobulin (IVIg) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Immunoglobulin (IVIg) as of 2021)
• Table 21. Intravenous Immunoglobulin (IVIg) Manufacturing Base Distribution and Headquarters
• Table 22. Manufacturers Intravenous Immunoglobulin (IVIg) Product Offered
• Table 23. Date of Manufacturers Enter into Intravenous Immunoglobulin (IVIg) Market
• Table 24. Mergers & Acquisitions, Expansion Plans
• Table 25. Global Intravenous Immunoglobulin (IVIg) Sales by Type (2017-2022) & (K Bottle)
• Table 26. Global Intravenous Immunoglobulin (IVIg) Sales by Type (2023-2028) & (K Bottle)
• Table 27. Global Intravenous Immunoglobulin (IVIg) Sales Share by Type (2017-2022)
• Table 28. Global Intravenous Immunoglobulin (IVIg) Sales Share by Type (2023-2028)
• Table 29. Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2017-2022) & (US$ Million)
• Table 30. Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2023-2028) & (US$ Million)
• Table 31. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2017-2022)
• Table 32. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2023-2028)
• Table 33. Intravenous Immunoglobulin (IVIg) Price by Type (2017-2022) & (USD/Bottle)
• Table 34. Global Intravenous Immunoglobulin (IVIg) Price Forecast by Type (2023-2028) & (USD/Bottle)
• Table 35. Global Intravenous Immunoglobulin (IVIg) Sales by Application (2017-2022) & (K Bottle)
• Table 36. Global Intravenous Immunoglobulin (IVIg) Sales by Application (2023-2028) & (K Bottle)
• Table 37. Global Intravenous Immunoglobulin (IVIg) Sales Share by Application (2017-2022)
• Table 38. Global Intravenous Immunoglobulin (IVIg) Sales Share by Application (2023-2028)
• Table 39. Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2017-2022) & (US$ Million)
• Table 40. Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2023-2028) & (US$ Million)
• Table 41. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Application (2017-2022)
• Table 42. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Application (2023-2028)
• Table 43. Intravenous Immunoglobulin (IVIg) Price by Application (2017-2022) & (USD/Bottle)
• Table 44. Global Intravenous Immunoglobulin (IVIg) Price Forecast by Application (2023-2028) & (USD/Bottle)
• Table 45. North America Intravenous Immunoglobulin (IVIg) Sales by Type (2017-2022) & (K Bottle)
• Table 46. North America Intravenous Immunoglobulin (IVIg) Sales by Type (2023-2028) & (K Bottle)
• Table 47. North America Intravenous Immunoglobulin (IVIg) Revenue by Type (2017-2022) & (US$ Million)
• Table 48. North America Intravenous Immunoglobulin (IVIg) Revenue by Type (2023-2028) & (US$ Million)
• Table 49. North America Intravenous Immunoglobulin (IVIg) Sales by Application (2017-2022) & (K Bottle)
• Table 50. North America Intravenous Immunoglobulin (IVIg) Sales by Application (2023-2028) & (K Bottle)
• Table 51. North America Intravenous Immunoglobulin (IVIg) Revenue by Application (2017-2022) & (US$ Million)
• Table 52. North America Intravenous Immunoglobulin (IVIg) Revenue by Application (2023-2028) & (US$ Million)
• Table 53. North America Intravenous Immunoglobulin (IVIg) Sales by Country (2017-2022) & (K Bottle)
• Table 54. North America Intravenous Immunoglobulin (IVIg) Sales by Country (2023-2028) & (K Bottle)
• Table 55. North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2017-2022) & (US$ Million)
• Table 56. North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2023-2028) & (US$ Million)
• Table 57. Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2017-2022) & (K Bottle)
• Table 58. Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2023-2028) & (K Bottle)
• Table 59. Europe Intravenous Immunoglobulin (IVIg) Revenue by Type (2017-2022) & (US$ Million)
• Table 60. Europe Intravenous Immunoglobulin (IVIg) Revenue by Type (2023-2028) & (US$ Million)
• Table 61. Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2017-2022) & (K Bottle)
• Table 62. Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2023-2028) & (K Bottle)
• Table 63. Europe Intravenous Immunoglobulin (IVIg) Revenue by Application (2017-2022) & (US$ Million)
• Table 64. Europe Intravenous Immunoglobulin (IVIg) Revenue by Application (2023-2028) & (US$ Million)
• Table 65. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2017-2022) & (K Bottle)
• Table 66. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2023-2028) & (K Bottle)
• Table 67. Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2017-2022) & (US$ Million)
• Table 68. Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2023-2028) & (US$ Million)
• Table 69. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Type (2017-2022) & (K Bottle)
• Table 70. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Type (2023-2028) & (K Bottle)
• Table 71. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Type (2017-2022) & (US$ Million)
• Table 72. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Type (2023-2028) & (US$ Million)
• Table 73. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Application (2017-2022) & (K Bottle)
• Table 74. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Application (2023-2028) & (K Bottle)
• Table 75. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Application (2017-2022) & (US$ Million)
• Table 76. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Application (2023-2028) & (US$ Million)
• Table 77. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (2017-2022) & (K Bottle)
• Table 78. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (2023-2028) & (K Bottle)
• Table 79. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region (2017-2022) & (US$ Million)
• Table 80. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region (2023-2028) & (US$ Million)
• Table 81. Latin America Intravenous Immunoglobulin (IVIg) Sales by Type (2017-2022) & (K Bottle)
• Table 82. Latin America Intravenous Immunoglobulin (IVIg) Sales by Type (2023-2028) & (K Bottle)
• Table 83. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Type (2017-2022) & (US$ Million)
• Table 84. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Type (2023-2028) & (US$ Million)
• Table 85. Latin America Intravenous Immunoglobulin (IVIg) Sales by Application (2017-2022) & (K Bottle)
• Table 86. Latin America Intravenous Immunoglobulin (IVIg) Sales by Application (2023-2028) & (K Bottle)
• Table 87. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Application (2017-2022) & (US$ Million)
• Table 88. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Application (2023-2028) & (US$ Million)
• Table 89. Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2017-2022) & (K Bottle)
• Table 90. Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2023-2028) & (K Bottle)
• Table 91. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (2017-2022) & (US$ Million)
• Table 92. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (2023-2028) & (US$ Million)
• Table 93. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Type (2017-2022) & (K Bottle)
• Table 94. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Type (2023-2028) & (K Bottle)
• Table 95. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Type (2017-2022) & (US$ Million)
• Table 96. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Type (2023-2028) & (US$ Million)
• Table 97. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Application (2017-2022) & (K Bottle)
• Table 98. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Application (2023-2028) & (K Bottle)
• Table 99. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Application (2017-2022) & (US$ Million)
• Table 100. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Application (2023-2028) & (US$ Million)
• Table 101. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2017-2022) & (K Bottle)
• Table 102. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2023-2028) & (K Bottle)
• Table 103. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2017-2022) & (US$ Million)
• Table 104. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2023-2028) & (US$ Million)
• Table 105. Baxter Corporation Information
• Table 106. Baxter Description and Major Businesses
• Table 107. Baxter Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
• Table 108. Baxter Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
• Table 109. Baxter Recent Developments
• Table 110. Grifols Corporation Information
• Table 111. Grifols Description and Major Businesses
• Table 112. Grifols Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
• Table 113. Grifols Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
• Table 114. Grifols Recent Developments
• Table 115. CSL Corporation Information
• Table 116. CSL Description and Major Businesses
• Table 117. CSL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
• Table 118. CSL Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
• Table 119. CSL Recent Developments
• Table 120. Octapharma Corporation Information
• Table 121. Octapharma Description and Major Businesses
• Table 122. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
• Table 123. Octapharma Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
• Table 124. Octapharma Recent Developments
• Table 125. Biotest Corporation Information
• Table 126. Biotest Description and Major Businesses
• Table 127. Biotest Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
• Table 128. Biotest Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
• Table 129. Biotest Recent Developments
• Table 130. Kedrion Corporation Information
• Table 131. Kedrion Description and Major Businesses
• Table 132. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
• Table 133. Kedrion Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
• Table 134. Kedrion Recent Developments
• Table 135. Hualan Bio Corporation Information
• Table 136. Hualan Bio Description and Major Businesses
• Table 137. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
• Table 138. Hualan Bio Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
• Table 139. Hualan Bio Recent Developments
• Table 140. CNBG Corporation Information
• Table 141. CNBG Description and Major Businesses
• Table 142. CNBG Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
• Table 143. CNBG Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
• Table 144. CNBG Recent Developments
• Table 145. Shanghai RAAS Corporation Information
• Table 146. Shanghai RAAS Description and Major Businesses
• Table 147. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
• Table 148. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
• Table 149. Shanghai RAAS Recent Developments
• Table 150. CBPO Corporation Information
• Table 151. CBPO Description and Major Businesses
• Table 152. CBPO Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
• Table 153. CBPO Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
• Table 154. CBPO Recent Developments
• Table 155. LFB Group Corporation Information
• Table 156. LFB Group Description and Major Businesses
• Table 157. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
• Table 158. LFB Group Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
• Table 159. LFB Group Recent Developments
• Table 160. BPL Corporation Information
• Table 161. BPL Description and Major Businesses
• Table 162. BPL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
• Table 163. BPL Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
• Table 164. BPL Recent Developments
• Table 165. Sichuan Yuanda Shuyang Corporation Information
• Table 166. Sichuan Yuanda Shuyang Description and Major Businesses
• Table 167. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
• Table 168. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
• Table 169. Sichuan Yuanda Shuyang Recent Developments
• Table 170. Key Raw Materials Lists
• Table 171. Raw Materials Key Suppliers Lists
• Table 172. Intravenous Immunoglobulin (IVIg) Distributors List
• Table 173. Intravenous Immunoglobulin (IVIg) Customers List
• Table 174. Intravenous Immunoglobulin (IVIg) Market Trends
• Table 175. Intravenous Immunoglobulin (IVIg) Market Drivers
• Table 176. Intravenous Immunoglobulin (IVIg) Market Challenges
• Table 177. Intravenous Immunoglobulin (IVIg) Market Restraints
• Table 178. Research Programs/Design for This Report
• Table 179. Key Data Information from Secondary Sources
• Table 180. Key Data Information from Primary Sources

List of Figures

• Figure 1. Intravenous Immunoglobulin (IVIg) Product Picture
• Figure 3. Global Intravenous Immunoglobulin (IVIg) Market Share by Type in 2021 & 2028
• Figure 3. IVIg Liquid Product Picture
• Figure 4. IVIg Powder Product Picture
• Figure 5. Global Intravenous Immunoglobulin (IVIg) Market Share by Application in 2021 & 2028
• Figure 6. Immunodeficiency
• Figure 7. Autoimmune Disease
• Figure 8. Acute Infection
• Figure 9. Intravenous Immunoglobulin (IVIg) Report Years Considered
• Figure 10. Global Intravenous Immunoglobulin (IVIg) Sales 2017-2028 (K Bottle)
• Figure 11. Global Intravenous Immunoglobulin (IVIg) Revenue, (US$ Million), 2017 VS 2021 VS 2028
• Figure 12. Global Intravenous Immunoglobulin (IVIg) Revenue 2017-2028 (US$ Million)
• Figure 13. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region in Percentage: 2021 Versus 2028
• Figure 14. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2017-2022)
• Figure 15. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2023-2028)
• Figure 16. North America Intravenous Immunoglobulin (IVIg) Sales YoY (2017-2028) & (K Bottle)
• Figure 17. North America Intravenous Immunoglobulin (IVIg) Revenue YoY (2017-2028) & (US$ Million)
• Figure 18. Europe Intravenous Immunoglobulin (IVIg) Sales YoY (2017-2028) & (K Bottle)
• Figure 19. Europe Intravenous Immunoglobulin (IVIg) Revenue YoY (2017-2028) & (US$ Million)
• Figure 20. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales YoY (2017-2028) & (K Bottle)
• Figure 21. Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue YoY (2017-2028) & (US$ Million)
• Figure 22. Latin America Intravenous Immunoglobulin (IVIg) Sales YoY (2017-2028) & (K Bottle)
• Figure 23. Latin America Intravenous Immunoglobulin (IVIg) Revenue YoY (2017-2028) & (US$ Million)
• Figure 24. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales YoY (2017-2028) & (K Bottle)
• Figure 25. Middle East & Africa Intravenous Immunoglobulin (IVIg) Revenue YoY (2017-2028) & (US$ Million)
• Figure 26. The Intravenous Immunoglobulin (IVIg) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
• Figure 27. The Top 5 and 10 Largest Manufacturers of Intravenous Immunoglobulin (IVIg) in the World: Market Share by Intravenous Immunoglobulin (IVIg) Revenue in 2021
• Figure 28. Global Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
• Figure 29. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2017-2028)
• Figure 30. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2017-2028)
• Figure 31. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2017-2028)
• Figure 32. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2017-2028)
• Figure 33. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2017-2028)
• Figure 34. North America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2017-2028)
• Figure 35. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2017-2028)
• Figure 36. North America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2017-2028)
• Figure 37. North America Intravenous Immunoglobulin (IVIg) Sales Share by Country (2017-2028)
• Figure 38. North America Intravenous Immunoglobulin (IVIg) Revenue Share by Country (2017-2028)
• Figure 39. U.S. Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
• Figure 40. Canada Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
• Figure 41. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2017-2028)
• Figure 42. Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2017-2028)
• Figure 43. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2017-2028)
• Figure 44. Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2017-2028)
• Figure 45. Europe Intravenous Immunoglobulin (IVIg) Sales Share by Country (2017-2028)
• Figure 46. Europe Intravenous Immunoglobulin (IVIg) Revenue Share by Country (2017-2028)
• Figure 47. Germany Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
• Figure 48. France Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
• Figure 49. U.K. Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
• Figure 50. Italy Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
• Figure 51. Russia Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
• Figure 52. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2017-2028)
• Figure 53. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2017-2028)
• Figure 54. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2017-2028)
• Figure 55. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2017-2028)
• Figure 56. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Share by Region (2017-2028)
• Figure 57. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue Share by Region (2017-2028)
• Figure 58. China Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
• Figure 59. Japan Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
• Figure 60. South Korea Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
• Figure 61. India Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
• Figure 62. Australia Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
• Figure 63. China Taiwan Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
• Figure 64. Indonesia Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
• Figure 65. Thailand Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
• Figure 66. Malaysia Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
• Figure 67. Latin America Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2017-2028)
• Figure 68. Latin America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2017-2028)
• Figure 69. Latin America Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2017-2028)
• Figure 70. Latin America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2017-2028)
• Figure 71. Latin America Intravenous Immunoglobulin (IVIg) Sales Share by Country (2017-2028)
• Figure 72. Latin America Intravenous Immunoglobulin (IVIg) Revenue Share by Country (2017-2028)
• Figure 73. Mexico Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
• Figure 74. Brazil Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
• Figure 75. Argentina Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
• Figure 76. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2017-2028)
• Figure 77. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2017-2028)
• Figure 78. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2017-2028)
• Figure 79. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2017-2028)
• Figure 80. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Share by Country (2017-2028)
• Figure 81. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue Share by Country (2017-2028)
• Figure 82. Turkey Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
• Figure 83. Saudi Arabia Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
• Figure 84. UAE Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
• Figure 85. Intravenous Immunoglobulin (IVIg) Value Chain
• Figure 86. Intravenous Immunoglobulin (IVIg) Production Process
• Figure 87. Channels of Distribution
• Figure 88. Distributors Profiles
• Figure 89. Bottom-up and Top-down Approaches for This Report
• Figure 90. Data Triangulation
• Figure 91. Key Executives Interviewed